Aurora Cannabis (NASDAQ:ACB) Issues Quarterly Earnings Results, Beats Expectations By $0.15 EPS

Aurora Cannabis (NASDAQ:ACB) released its quarterly earnings results on Wednesday. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.15, Zacks reports. Aurora Cannabis had a negative net margin of 17.47% and a negative return on equity of 2.19%.

Aurora Cannabis Stock Up 49.9 %

NASDAQ ACB traded up $1.84 on Wednesday, hitting $5.52. 42,119,729 shares of the company were exchanged, compared to its average volume of 2,240,929. Aurora Cannabis has a 12 month low of $2.84 and a 12 month high of $9.35. The company has a current ratio of 3.83, a quick ratio of 1.88 and a debt-to-equity ratio of 0.07. The company has a market cap of $302.72 million, a PE ratio of -7.21 and a beta of 1.85. The stock has a fifty day moving average of $4.19 and a 200-day moving average of $5.16.

Analysts Set New Price Targets

A number of brokerages recently weighed in on ACB. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th. TD Cowen assumed coverage on Aurora Cannabis in a research report on Wednesday, December 11th. They issued a “buy” rating for the company.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.